These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1503623)

  • 41. Interleukin-19 Levels Are Increased in Palmoplantar Pustulosis and Reduced following Apremilast Treatment.
    Wolk K; Wilsmann-Theis D; Witte K; Brembach TC; Kromer C; Gerdes S; Ghoreschi K; Reich K; Mössner R; Sabat R
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Delayed-type hypersensitivity in palmoplantar pustulosis: effect of cyclosporin A treatment on skin testing with recall antigens.
    Remitz A; Lauerma AI; Erkko P; Reitamo S
    Acta Derm Venereol; 1996 Jul; 76(4):310-3. PubMed ID: 8869692
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful treatment of severe arthralgia associated with palmoplantar pustulosis with low-dose oral cyclosporine A.
    Yamamoto T; Kimura K; Katayama I; Nishioka K
    J Dermatol; 1995 Jul; 22(7):512-4. PubMed ID: 7560444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The cutaneous non-neuronal cholinergic system and smoking related dermatoses: studies of the psoriasis variant palmoplantar pustulosis.
    Hagforsen E
    Life Sci; 2007 May; 80(24-25):2227-34. PubMed ID: 17341425
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Epidemiology of Palmoplantar Pustulosis: An Analysis of Multiple Health Insurance Claims and Electronic Health Records Databases.
    Ramcharran D; Strober B; Gordon K; DeKlotz C; Fakharzadeh S; Yang YW; Swerdel J; Hardin J; Dronavalli S; Paller AS
    Adv Ther; 2023 Nov; 40(11):5090-5101. PubMed ID: 37737889
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments.
    Misiak-Galazka M; Zozula J; Rudnicka L
    Am J Clin Dermatol; 2020 Jun; 21(3):355-370. PubMed ID: 32008176
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial.
    Bissonnette R; Nigen S; Langley RG; Lynde CW; Tan J; Fuentes-Duculan J; Krueger JG
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1298-305. PubMed ID: 24112799
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic histopathological features distinguishing palmoplantar pustulosis from pompholyx.
    Masuda-Kuroki K; Murakami M; Kishibe M; Kobayashi S; Okubo Y; Yamamoto T; Terui T; Sayama K
    J Dermatol; 2019 May; 46(5):399-408. PubMed ID: 30919463
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retrospective study of the clinical significance of the neutrophil-to-lymphocyte ratio in 79 patients with palmoplantar pustulosis.
    Watanabe T; Watanabe Y; Asai C; Asami M; Takamura N; Yamaguchi Y
    J Dermatol; 2024 May; ():. PubMed ID: 38760982
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel findings of Langerhans cells and interleukin-17 expression in relation to the acrosyringium and pustule in palmoplantar pustulosis.
    Hagforsen E; Hedstrand H; Nyberg F; Michaëlsson G
    Br J Dermatol; 2010 Sep; 163(3):572-9. PubMed ID: 20426778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of granulocyte and monocyte adsorption apheresis for treatment of palmoplantar pustulosis.
    Fujisawa T; Tawada C; Mizutani Y; Doi T; Yoshida S; Ogura S; Seishima M
    Ther Apher Dial; 2014 Jun; 18(3):238-43. PubMed ID: 24965289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Histological differentiation between palmoplantar pustulosis and pompholyx.
    Yoon SY; Park HS; Lee JH; Cho S
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):889-93. PubMed ID: 22691103
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis.
    Bissonnette R; Maari C; Tsianakas A; Reid D; McCutchan S; Baumgartner S; Mackay J; Bhakta N
    Dermatol Ther (Heidelb); 2021 Dec; 11(6):2179-2193. PubMed ID: 34716902
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immediate response to apremilast in patients with palmoplantar pustulosis: a retrospective pilot study.
    Kato N; Takama H; Ando Y; Yanagishita T; Ohshima Y; Ohashi W; Akiyama M; Watanabe D
    Int J Dermatol; 2021 May; 60(5):570-578. PubMed ID: 33454961
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Generalized pustular psoriasis following withdrawal of oral cyclosporin treatment for palmo-plantar pustulosis.
    De Silva BD; Benton EC; Tidman MJ
    Clin Exp Dermatol; 1999 Jan; 24(1):10-3. PubMed ID: 10233640
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Rare Case of New-Onset Crohn's Disease in a Patient With Chronic Palmoplantar Pustulosis.
    Tanida S; Yoshii S; Kubo R; Takahama T; Sasoh S; Kubota Y; Ban T; Ando T; Nakamura M; Joh T
    J Clin Med Res; 2023 Apr; 15(4):243-249. PubMed ID: 37187712
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of ustekinumab in refractory palmoplantar pustular psoriasis.
    Morales-Múnera C; Vilarrasa E; Puig L
    Br J Dermatol; 2013 Apr; 168(4):820-4. PubMed ID: 23210683
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical characteristics and associations of palmoplantar pustulosis: an observational study.
    Oktem A; Uysal PI; Akdoğan N; Tokmak A; Yalcin B
    An Bras Dermatol; 2020; 95(1):15-19. PubMed ID: 31899067
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A double-blind, placebo-controlled trial of topical PUVA in persistent palmoplantar pustulosis.
    Layton AM; Sheehan-Dare R; Cunliffe WJ
    Br J Dermatol; 1991 Jun; 124(6):581-4. PubMed ID: 2064943
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Possible Efficacy of Vedolizumab, an Anti-α4β7 Integrin Antibody, in Palmoplantar Pustulosis.
    Terui H; Moroi R; Masamune A; Aiba S; Yamasaki K
    Case Rep Dermatol; 2023; 15(1):22-25. PubMed ID: 36726801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.